Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (3)
  • FXR
    (2)
  • GPCR19
    (2)
  • Angiotensin-converting Enzyme (ACE)
    (1)
  • Apoptosis
    (1)
  • Caspase
    (1)
  • ERK
    (1)
  • Potassium Channel
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
  • Metabolism
    (2)
  • Digestive System
    (1)
  • Endocrine system
    (1)
  • Infection
    (1)
  • Inflammation
    (1)
Filter
Search Result
Results for "

ursodiol

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Natural Products
    2
    TargetMol | Natural_Products
  • Isotope Products
    1
    TargetMol | Isotope_Products
Ursodeoxycholic acid sodium
Ursodiol sodium, Ursodeoxycholic Acid (sodium salt), Ursodeoxycholate sodium, UDCA sodium, UDCA Na, Sodium Ursodeoxycholate
T290782898-95-5In house
Ursodeoxycholic acid sodium (Sodium Ursodeoxycholate) is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,
  • $29
In Stock
Size
QTY
Ursodeoxycholic acid
Ursodiol, UDCA
T0700128-13-2
Ursodeoxycholic acid (UDCA) is a potent inhibitor of liver-specific fatty acid transporter 5 (FATP5). Ursodeoxycholic acid inhibits cholesterol absorption and is used to dissolve gallstones.
  • $42
In Stock
Size
QTY
TargetMol | Citations Cited
Tauroursodeoxycholic-d4 Acid
Tauroursodiol-d4
TMIJ-01992410279-94-4
Tauroursodeoxycholic-d4 Acid is a deuterated compound of Tauroursodeoxycholic Acid. Tauroursodeoxycholic Acid has a CAS number of 14605-22-2. Tauroursodeoxycholate, also known as ursodoxicoltaurine, is a highly hydrophilic tertiary bile acid that is produced in humans at a low concentration. Tauroursodeoxycholate is the more hydrophilic form of ursodeoxycholic acid, which is the more abundant naturally produced bile acid in humans.Tauroursodeoxycholate is being investigated for use in several conditions such as Primary Biliary Cirrhosis (PBC), insulin resistance, amyloidosis, Cystic Fibrosis, Cholestasis, and Amyotrophic Lateral Sclerosis.
  • $578
35 days
Size
QTY